Experts Optimistic About Melanoma Vaccine
HealthDay – A vaccine for advanced melanoma has shown promise in a new study. Melanoma is the most serious type of skin cancer. The study, a phase 3 clinical trial involving 185 people, found that using the peptide vaccine in combination with the immunotherapy drug improved response rates and progression-free survival.
Short URL: http://www.news.synavista.com/?p=3115
Posted by admin
on May 31 2009. Filed under Health News.
You can follow any responses to this entry through the RSS 2.0.
Both comments and pings are currently closed.
